David E Walker, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Flat Rock Pl, 2nd Fl, Westbrook, CT 06498 Phone: 860-358-3640 Fax: 860-358-8656 |
Gregory J Kundrat, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Grove Beach Rd North, Building 1, Unit A, Westbrook, CT 06498 Phone: 860-664-3553 Fax: 860-664-3756 |
Jason Ziegler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Flat Rock Pl, Westbrook, CT 06498 Phone: 860-358-3640 Fax: 860-358-8656 |
Shane Thomas Ridge, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Flat Rock Pl, 2nd Fl, Westbrook, CT 06498 Phone: 860-358-3640 Fax: 860-358-8656 |
Valerie M Small, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Flat Rock Pl, 2nd Fl, Westbrook, CT 06498 Phone: 860-358-3640 Fax: 860-358-8656 |
Dr. Juliette Nedah Harris, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Flat Rock Pl, Westbrook, CT 06498 Phone: 860-358-3640 |
Jeong Eun Oh, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Grove Beach Rd N, Bldg1, Unit A, Westbrook, CT 06498 Phone: 860-664-3553 Fax: 860-358-8656 |
News Archive
Obese teenagers who don't get the proper amount of sleep may have disruptions in insulin secretion and blood sugar (glucose) levels, say pediatric researchers. Their study suggests that getting a good night's sleep may stave off the development of type 2 diabetes in these adolescents.
"Exceptional, Unconventional Research Enabling Knowledge Acceleration" - is the name of a rare and competitive grant that Reenan recently won from the National Institutes of Health. Beginning April 1, Reenan will use the four-year, $1.3-million award to look for genes that can suppress seizures in fruit flies that he has cleverly engineered to mimic human epilepsy.
TechPrecision Corporation (OTC Bulletin Board: TPCS) ("TechPrecision", or "the Company"), a leading manufacturer of large-scale, high-precision machined metal fabrications with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today released the following open letter to shareholders reviewing the highlights of 2009 and providing an overview of the Company's strategic plan and outlook for 2010.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has received a Ringier Technology Innovation Award for its role in helping Chinese laboratories quickly develop melamine detection capabilities following the discovery of melamine-tainted milk and infant formula in China. The award was presented by Ringier Trade Publishing, which publishes China's leading food industry magazine, Food Manufacturing Journal.
NanoViricides, Inc. announced today that its previously announced pre-IND Meeting was held with the USFDA on March 29th, 2012, as scheduled. This pre-IND meeting focused on FluCide, designated as NV-INF-1, the Company's novel anti-influenza drug.
› Verified 6 days ago